Department of Anesthesiology
Author Title Type [ Year(Desc)]
Filters: Keyword is Adolescent  [Clear All Filters]
1964
PICOLLO AR.  1964.  CLINICAL CASES-HOMEOPATHIC TREATMENT.. Hahnemannian. 99:6-7.
1965
Gadalla FR.  1965.  Factors involved in the attendance to bilharzia treatment.. J Egypt Public Health Assoc. 40(6):425-38.
1974
Donlon JV, Ali HH, Savarese JJ.  1974.  A new approach to the study of four nondepolarizing relaxants in man.. Anesth Analg. 53(6):934-9.
1975
Savarese JJ, Ali HH, Murphy JD, Padget C, Lee CM, Ponitz J.  1975.  Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.. Anesthesiology. 42(1):106-11.
1978
Mitchell MM, Ali HH, Savarese JJ.  1978.  Myotonia and neuromuscular blocking agents.. Anesthesiology. 49(1):44-8.
1980
Donlon JV, Savarese JJ, Ali HH, Teplik RS.  1980.  Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis.. Anesthesiology. 53(2):161-6.
Martyn JA, Szyfelbein SK, Ali HH, Matteo RS, Savarese JJ.  1980.  Increased d-tubocurarine requirement following major thermal injury.. Anesthesiology. 52(4):352-5.
1982
Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.  1982.  Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.
1985
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
1986
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
Tjeuw MT, Yao FS, Van Poznak A.  1986.  Depressant effects of anesthetics on isolated human gravid and non-gravid uterine muscle.. Chin Med J (Engl). 99(3):235-42.
1988
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.  1988.  Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.  1988.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.
Goldhill DR, Embree PB, Ali HH, Savarese JJ.  1988.  Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.. Anaesthesia. 43(6):443-6.
1989
Savarese JJ, Ali HH, Basta SJ, Scott RP, Embree PB, Wastila WB, Abou-Donia MM, Gelb C.  1989.  The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia.. Anesthesiology. 70(3):386-94.
1993
Redo SF, Dinner MH.  1993.  Placement of central venous catheters by cut-down with electrocardiogram positioning.. Surg Gynecol Obstet. 177(1):49-53.
1995
Fong J, Johnston S, Valentino T, Notterman D.  1995.  Length/serum creatinine ratio does not predict measured creatinine clearance in critically ill children.. Clin Pharmacol Ther. 58(2):192-7.
1996
Lien CA, Hemmings HC, Belmont MR, Abalos A, Hollmann C, Kelly RE.  1996.  A comparison: the efficacy of sevoflurane-nitrous oxide or propofol-nitrous oxide for the induction and maintenance of general anesthesia.. J Clin Anesth. 8(8):639-43.
2001
Ivascu NS, Sarnaik S, McCrae J, Whitten-Shurney W, Thomas R, Bond S.  2001.  Characterization of pica prevalence among patients with sickle cell disease.. Arch Pediatr Adolesc Med. 155(11):1243-7.
2002
Schlame M, Towbin JA, Heerdt PM, Jehle R, DiMauro S, Blanck TJJ.  2002.  Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.. Ann Neurol. 51(5):634-7.
2003
Suzuki T, Lien CA, Belmont MR, Tjan J, Savarese JJ.  2003.  Edrophonium effectively antagonizes neuromuscular block at the laryngeal adductors induced by rapacuronium, rocuronium and cisatracurium, but not mivacurium.. Can J Anaesth. 50(9):879-85.
2004
Belmont MR, Lien CA, Tjan J, Bradley E, Stein B, Patel SS, Savarese JJ.  2004.  Clinical pharmacology of GW280430A in humans.. Anesthesiology. 100(4):768-73.
Crystal RG, Sondhi D, Hackett NR, Kaminsky SM, Worgall S, Stieg P, Souweidane M, Hosain S, Heier L, Ballon D et al..  2004.  Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosis.. Hum Gene Ther. 15(11):1131-54.
2005
Tu J, Stoodley MA, Morgan MK, Storer KP.  2005.  Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations.. J Neurosurg. 103(5):903-9.
2006
Tu J, Stoodley MA, Morgan MK, Storer KP.  2006.  Responses of arteriovenous malformations to radiosurgery: ultrastructural changes.. Neurosurgery. 58(4):749-58;discussion749-58.